Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glycolysis-induced drug resistance in tumors—A response to danger signals?
Fabrizio Marcucci, Cristiano Rumio
Neoplasia (2021) Vol. 23, Iss. 2, pp. 234-245
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Modulating Glycolysis to Improve Cancer Therapy
Chaithanya Chelakkot, Vipin Shankar Chelakkot, Young Kee Shin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2606-2606
Open Access | Times Cited: 164
Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management
Ping Jin, Jingwen Jiang, Li Zhou, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 122
Emerging therapies in cancer metabolism
Yi Xiao, Tian‐Jian Yu, Ying Xu, et al.
Cell Metabolism (2023) Vol. 35, Iss. 8, pp. 1283-1303
Open Access | Times Cited: 91
Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance
Hong Lin, Di Wang, Pinghan Wang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 84
Impact of cancer metabolism on therapy resistance – Clinical implications
Ana Cristina Gonçalves, Elena Richiardone, Joana Jorge, et al.
Drug Resistance Updates (2021) Vol. 59, pp. 100797-100797
Open Access | Times Cited: 89
Targeting lactate-related cell cycle activities for cancer therapy
Jia Lin, Geng Liu, Lidian Chen, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 1231-1243
Closed Access | Times Cited: 42
Significance of flavonoids targeting PI3K/Akt/HIF-1α signaling pathway in therapy-resistant cancer cells – A potential contribution to the predictive, preventive, and personalized medicine
Alena Mazuráková, Lenka Koklesová, Sandra Hurta Csizmár, et al.
Journal of Advanced Research (2023) Vol. 55, pp. 103-118
Open Access | Times Cited: 30
Immune checkpoints between epithelial-mesenchymal transition and autophagy: A conflicting triangle
Marco Cordani, Raffaele Strippoli, Flavia Trionfetti, et al.
Cancer Letters (2024) Vol. 585, pp. 216661-216661
Open Access | Times Cited: 9
Fibrous stroma: Driver and passenger in cancer development
Vandana Sharma, Joshua Letson, Saori Furuta
Science Signaling (2022) Vol. 15, Iss. 724
Open Access | Times Cited: 28
Targeting glycolysis for cancer therapy using drug delivery systems
Yongzhuo Huang
Journal of Controlled Release (2022) Vol. 353, pp. 650-662
Closed Access | Times Cited: 28
Correlation between the Warburg effect and progression of triple-negative breast cancer
Shaojun Liu, Yuxuan Li, Meng Yuan, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 20
Inhibition of glycolysis and SIRT1/GLUT1 signaling ameliorates the apoptotic effect of Leptosidin in prostate cancer cells
Youngsang Park, Hyo‐Jung Lee, Deok Yong Sim, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 3, pp. 1235-1244
Closed Access | Times Cited: 6
Unveiling the potential of FOXO3 in lung cancer: From molecular insights to therapeutic prospects
Mohammad Ebrahimnezhad, Amir Valizadeh, Maryam Majidinia, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116833-116833
Open Access | Times Cited: 6
The Role of Circular RNAs in the Drug Resistance of Cancers
Xinyuan Liu, Qi Zhang, Jing Guo, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 25
Drug Resistance in Cancers: A Free Pass for Bullying
Jing Li, Xiao Li, Qie Guo
Cells (2022) Vol. 11, Iss. 21, pp. 3383-3383
Open Access | Times Cited: 23
Melatonin inhibits bladder tumorigenesis by suppressing PPARγ/ENO1-mediated glycolysis
Dexin Shen, Zhao Deng, Wei Liu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 4
Open Access | Times Cited: 16
The CAIX inhibitor SLC-0111 exerts anti-cancer activity on gastric cancer cell lines and resensitizes resistant cells to 5-Fluorouracil, taxane-derived, and platinum-based drugs
Elena Andreucci, Alessio Biagioni, Sara Peri, et al.
Cancer Letters (2023) Vol. 571, pp. 216338-216338
Open Access | Times Cited: 15
Wnt/β-Catenin Signaling as a Driver of Stemness and Metabolic Reprogramming in Hepatocellular Carcinoma
Rainbow Wing Hei Leung, Terence K. Lee
Cancers (2022) Vol. 14, Iss. 21, pp. 5468-5468
Open Access | Times Cited: 20
On the Role of Glycolysis in Early Tumorigenesis—Permissive and Executioner Effects
Fabrizio Marcucci, Cristiano Rumio
Cells (2023) Vol. 12, Iss. 8, pp. 1124-1124
Open Access | Times Cited: 12
Hypoxic regulation of extracellular vesicles: Implications for cancer therapy
Seongkyeong Yoo, Sanga Choi, Iljin Kim, et al.
Journal of Controlled Release (2023) Vol. 363, pp. 201-220
Closed Access | Times Cited: 11
A Narrative Review of Prognostic Gene Signatures in Oral Squamous Cell Carcinoma Using LASSO Cox Regression
Nur Fatinazwa Mohd Faizal, Saptarsi Shai, Bansi Savaliya, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 134-134
Open Access
Prostate cancer cells elevate glycolysis and G6PD in response to caffeic acid phenethyl ester-induced growth inhibition
Tzu-Ping Lin, Pei‐Chun Chen, Ching-Yu Lin, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Exploring glycolytic enzymes in disease: potential biomarkers and therapeutic targets in neurodegeneration, cancer and parasitic infections
Maura Rojas-Pirela, Diego Andrade-Alviárez, Verónica Rojas, et al.
Open Biology (2025) Vol. 15, Iss. 2
Open Access
Mitochondria-associated non-coding RNAs and their impact on drug resistance
Xingna An, Lina Sun, Huan Zheng, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Targeting glycolysis in esophageal squamous cell carcinoma: single-cell and multi-omics insights for risk stratification and personalized therapy
Yan Wang, Y. Shi, Xiao Hu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Page 1 - Next Page

Scroll to top